Bayesian Capital Management’s Seagen Inc. Common Stock SGEN Stock Holding History

Bayesian Capital Management’s Portfolio SGEN Stock Details SGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-10,500	Closed	-$2.13M	–	1137
2023 Q1	$2.13M	Buy	+10,500	New	+$1.68M	0.26%	103
2020 Q1	–	Sell	-4,081	Closed	-$466K	–	1026
2019 Q4	$466K	Buy	+4,081	New	+$433K	0.08%	321
2018 Q1	–	Sell	-3,800	Closed	-$203K	–	869
2017 Q4	$203K	Buy	+3,800	New	+$222K	0.04%	493

Other funds holding SGEN

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bayesian Capital Management's SGEN Position: Q2 2023 in Review

Bayesian Capital Management sold out of Seagen Inc. Common Stock (SGEN) in Q2 2023, closing a stake of 10,500 shares — an estimated $2.13M sold.

Bayesian Capital Management first reported a position in SGEN in Q4 2017 and held it in 3 quarters. The position peaked at $2.13M in Q1 2023. 594 funds tracked by Wall St. Rank hold SGEN as of Q2 2023.

Bayesian Capital Management reported no remaining Seagen Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Bayesian Capital Management sold 10,500 Seagen Inc. Common Stock shares in Q2 2023, an estimated $2.13M.
Bayesian Capital Management first reported a position in Seagen Inc. Common Stock in Q4 2017 and held it in 3 quarters.
Bayesian Capital Management's Seagen Inc. Common Stock position peaked at $2.13M in Q1 2023.
594 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q2 2023.

Based on Bayesian Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.